Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress

BACKGROUND: Rb3 is a ginsenoside with anti-inflammatory properties in many cell types and has been reported to attenuate inflammation-related metabolic diseases such as insulin resistance, nonalcoholic fatty liver disease, and cardiovascular disease. However, the effect of Rb3 on podocyte apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Heeseung, Cho, Wonjun, Park, Seung Yeon, Abd El-Aty, A.M., Jeong, Ji Hoon, Jung, Tae Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214284/
https://www.ncbi.nlm.nih.gov/pubmed/37252277
http://dx.doi.org/10.1016/j.jgr.2022.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214284/
https://www.ncbi.nlm.nih.gov/pubmed/37252277
http://dx.doi.org/10.1016/j.jgr.2022.11.006

Ejemplares similares